No Detail Found!

Study on the pharmacokinetics of tacrolimus in depression model rats.

Author(s)
Jingjing Duan Department of Pharmacy, Sixth People Hospital South Campus, Shanghai Jiaotong University, Shanghai, China
Yingtong Zeng Department of Pharmacy, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
Ting Zhou Department of Pharmacy, Sixth People Hospital South Campus, Shanghai Jiaotong University, Shanghai, China
Ye Zhang Department of Pharmacy, Sixth People Hospital South Campus, Shanghai Jiaotong University, Shanghai, China
Feng Xu Department of Pharmacy, Sixth People Hospital South Campus, Shanghai Jiaotong University, Shanghai, China
Abstract
Drug metabolism is affected by many social-psychological factors including mood disorder. Organ transplantation recipients usually suffer from depression. The study aims to explore whether depression disorder alters immunosuppresant Tacrolimus (TAC) pharmacokinetic process in depression model rats. Eighteen female Sprague-Dawley (SD) rats were randomized into model group and control group. Depression model rats were built with Chronic Unpredicted Mild Stresses (GUMS) for 8 weeks. After 8 weeks model establishment, all rats in both groups were given TAC (1.5 mg kg-1) i.g. Blood samples were collected at various time points. TAC concentration was assayed by high performance liquid chromatography-tandem mass spectrometry (I-TPLC-MS/MS). TAC pharmacokinetic parameters were processed with DAS software. Compared to those in control group, there was significant decrease in Cm. and AUC in depression model group (p
Publication Details
Page(s) 265-270
DOI DOI not available
Published Journal: International Journal of Pharmacology, Volume: 9, Issue: 4, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

42

Views